Abstract
Background
Treatment of scarring has long been a problem due to high incidence and recurrence. Despite many existing treatment therapies, the efficacy remains unstable.
Objectives
To determine the efficacy and safety of skin biopsy punch in combination with corticosteroid injection (BPCI) in treating keloids.
Approach
This was a retrospective study. In total, 16 patients with keloids received BPCI. Changes in scar appearance, accompanied symptoms, and Vancouver Scar Scale (VSS) were analyzed. Patient satisfaction, VAS scores, and adverse effects were also evaluated.
Results
Scar appearance, accompanied symptoms, and VSS scores improved significantly after the treatment. The total effective rate was 93.75% at an 18-month follow-up on average. The mean reduction rate of VSS score was 58.44% (p < 0.0001), especially in height and pliability (84.44% and 78.19%, p < 0.0001). The recurrence rate in this study was 12.5% (n = 2) at an 18-month follow-up on average. Mild adverse effects of pain, pruritus, hypopigmentation, and telangiectasia were recorded.
Conclusions
This study demonstrated BPCI might be an effective and safe therapy in keloids with a low long-time recurrence rate and well tolerance for patients.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
Data Availability
The text and image data of patients used to support the findings of this study are restricted by the Medical Ethics Committee of Dermatology Hospital of Southern Medical University in order to protect PATIENT PRIVACY. Data are available from Yixin Li, 2204170401@csu.edu.cn for researchers who meet the criteria for access to confidential data.
References
Wolfram D, Tzankov A, Pulzl P et al (2009) Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35(2):171–181
Gauglitz GG, Korting HC, Pavicic T et al (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125
Robles DT, Berg D (2007) Abnormal wound healing: keloids. Clin Dermatol 25(1):26–32
Sen CK, Gordillo GM, Roy S et al (2009) Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17(6):763–771
Berman B, Bieley HC (1996) Adjunct therapies to surgical management of keloids. Dermatol Surg 22(2):126–130
Gold MH, McGuire M, Mustoe TA et al (2014) Updated international clinical recommendations on scar management: part 2–algorithms for scar prevention and treatment. Dermatol Surg 40(8):825–831
Morelli Coppola M, Salzillo R, Segreto F, Persichetti P (2018) Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol 11:387–396
Leventhal D, Furr M, Reiter D (2006) Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 8(6):362–368
Kural MH, Billiar KL (2016) Myofibroblast persistence with real-time changes in boundary stiffness. Acta Biomater 32:223–230
Ledon JA, Savas J, Franca K et al (2013) Intralesional treatment for keloids and hypertrophic scars: a review. Dermatol Surg 39(12):1745–1757
Wilson AM (2013) Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin. Can J Plast Surg 21(2):87–91
Lee SY, Park J (2015) Postoperative electron beam radiotherapy for keloids: treatment outcome and factors associated with occurrence and recurrence. Ann Dermatol 27(1):53–58
Lee YI, Kim J, Yang CE et al (2019) Combined therapeutic strategies for keloid treatment. Dermatol Surg 45(6):802–810
Bijlard E, Timman R, Verduijn GM et al (2018) Intralesional cryotherapy versus excision with corticosteroid injections or brachytherapy for keloid treatment: randomised controlled trials. J Plast Reconstr Aesthet Surg 71(6):847–856
Butler PD, Longaker MT, Yang GP (2008) Current progress in keloid research and treatment. J Am Coll Surg 206(4):731–741
Wang H, Zhao W, Xu M et al (2021) Treatment of keloids by surgical excision combined with 5-fluorouracil and betamethasone injection. Dermatol Surg 47(5):740–741
Naik PP (2022) Novel targets and therapies for keloid. Clin Exp Dermatol 47(3):507–515
Sohrabi C, Goutos I (2020) The use of botulinum toxin in keloid scar management: a literature review. Scars Burn Heal 6:2059513120926628
Wang P, Gu L, Bi H et al (2021) Comparing the Efficacy and Safety of Intralesional verapamil with Intralesional triamcinolone Acetonide in treatment of hypertrophic scars and keloids: a meta-analysis of randomized controlled trials. Aesthet Surg J 41(6):np567–np575
Hussein Ali E, Adnan SS (2019) Effect of collagenase ointment versus moist exposed burn ointment on healing of full-thickness burns in mice by removing of necrotic tissue. Dermatol Ther 32(1):e12769
Baryza MJ, Baryza GA (1995) The Vancouver scar scale: an administration tool and its interrater reliability. J Burn Care Rehabil 16(5):535–538
Reed MD, Van Nostran W (2014) Assessing pain intensity with the visual analog scale: a plea for uniformity. J Clin Pharmacol 54(3):241–244
Ogawa R (2022) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg 149(1):79e–94e
Gurtner GC, Dauskardt RH, Wong VW et al (2011) Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies. Ann Surg 254(2):217–225
Rustad KC, Wong VW, Gurtner GC (2013) The role of focal adhesion complexes in fibroblast mechanotransduction during scar formation. Differentiation 86(3):87–91
Artz M, Trimaille A, Labouche A et al (2022) Outcomes associated with combination shaving and cryosurgery treatment in patients with keloid scars. JAMA Dermatol 158(8):956–958
Azzam EZ, Omar SS (2018) Treatment of auricular keloids by triple combination therapy: surgical excision, platelet-rich plasma, and cryosurgery. J Cosmet Dermatol 17(3):502–510
van Leeuwen MCE, van der Wal MBA, Bulstra AJ et al (2015) Intralesional cryotherapy for treatment of keloid scars: a prospective study. Plast Reconstr Surg 135(2):580–589
Harn HI, Ogawa R, Hsu CK et al (2019) The tension biology of wound healing. Exp Dermatol 28(4):464–471
Burd A, Huang L (2005) Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg 116(7):150e–157e
Choi YJ, Lee YH, Lee HJ et al (2020) Auricular keloid management in Asian skin: clinical outcome of intralesional excision and postoperative triamcinolone acetonide intralesional injection. J Cosmet Dermatol 19(11):3041–3047
Ogawa R, Akaishi S, Dohi T et al (2015) Analysis of the surgical treatments of 63 keloids on the cartilaginous part of the auricle: effectiveness of the core excision method. Plast Reconstr Surg 135(3):868–875
McCoy BJ, Diegelmann RF, Cohen IK (1980) In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 163(2):216–222
Tan S, Khumalo N, Bayat A (2019) Understanding keloid pathobiology from a quasi-neoplastic perspective: less of a scar and more of a chronic inflammatory disease with cancer-like tendencies. Front Immunol 10:1810
Al-Attar A, Mess S, Thomassen JM et al (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117(1):286–300
Mankowski P, Kanevsky J, Tomlinson J et al (2017) Optimizing radiotherapy for keloids: a meta-analysis systematic review comparing recurrence rates between different radiation modalities. Ann Plast Surg 78(4):403–411
Son Y, Phillips EON, Price KM et al (2020) Treatment of keloids with a single dose of low-energy superficial X-ray radiation to prevent recurrence after surgical excision: an in vitro and in vivo study. J Am Acad Dermatol 83(5):1304–1314
Bijlard E, Steltenpool S, Niessen FB (2015) Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol 95(7):778–782
Erlendsson AM, Anderson RR, Manstein D et al (2014) Developing technology: ablative fractional lasers enhance topical drug delivery. Dermatol Surg 40(Suppl 12):S142–S146
Dhurat R, Daruwalla SB, Sharma A (2019) Fractionated de-volumizing Keloid tissue—the “pop” method—a novel technique to facilitate administration of intralesional corticosteroid in difficult keloids. J Am Acad Dermatol 88(2):e75–e77
Wang P, Wang Q, Yang X et al (2023) Targeting the glycolytic enzyme pgk1 to inhibit the Warburg effect: a new strategy for keloid therapy. Plast Reconstr Surg 151(6):970e–980e
Acknowledgments
None.
Funding
None.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Human and Animal Rights
This study was approved by the Ethics Committee of the Dermatology Hospital of Southern Medical University (Approved number: 2021003).
Informed Consent
Patient provided informed consent to participate in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, Y., Dong, J., Liu, L. et al. Smart Use of Skin Biopsy Punch in Treating Keloids: A Single-Center Retrospective Study. Aesth Plast Surg (2024). https://doi.org/10.1007/s00266-024-04000-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00266-024-04000-6